Effect of Mat Pilates Training on Women After Menopause
1 other identifier
interventional
50
1 country
1
Brief Summary
This project aims to verify the chronic effect of Mat Pilates exercise on climacteric symptoms, ambulatory blood pressure responses, lipid and glucose profile and pro and anti-inflammatory and antioxidant markers in postmenopausal normotensive and hypertensive women. All volunteers received the same intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2017
CompletedStudy Start
First participant enrolled
August 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2018
CompletedFirst Posted
Study publicly available on registry
August 13, 2018
CompletedMarch 22, 2022
March 1, 2022
5 months
April 24, 2017
March 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure
Resting diastolic and systolic blood pressures will be monitored by Microlife® BP 3BT0A automatic monitor in mmHg.
Change from Baseline at 12 weeks
Secondary Outcomes (5)
Ambulatory blood pressure monitoring
Change from Baseline at 12 weeks
Kupperman - Blatt Index
Change from Baseline at 12 weeks
Cervical Scale
Change from Baseline at 12 weeks
Menopause Rating Scale (MRS)
Change from Baseline at 12 weeks
Sleep quality
Change from Baseline at 12 weeks
Other Outcomes (1)
Biochemical analyzes
Change from Baseline at 12 weeks
Study Arms (2)
Hypertensive group
OTHERThe Mat Pilates session was held lasting 50 minutes of exercises with the first 5 minutes heating and in each exercise performing 10 repetitions with 45 seconds of rest between one exercise and another. For practice, are used only mats, and alternative devices such as the Swiss ball and the flexible ring, as well as body weight and the force of gravity as resistance factors and Borg's subjective perception of effort scale for intensity parameters. The 20 exercises were chosen through the classic exercises thus classified by the creator of the Joseph Pilates method.During the sessions, volunteers were instructed on correct breathing without performing the valsalva maneuver.
Normotensive group
OTHERThe Mat Pilates session was held lasting 50 minutes of exercises with the first 5 minutes heating and in each exercise performing 10 repetitions with 45 seconds of rest between one exercise and another. For practice, are used only mats, and alternative devices such as the Swiss ball and the flexible ring, as well as body weight and the force of gravity as resistance factors and Borg's subjective perception of effort scale for intensity parameters. The 20 exercises were chosen through the classic exercises thus classified by the creator of the Joseph Pilates method.During the sessions, volunteers were instructed on correct breathing without performing the valsalva maneuver.
Interventions
Pilates 12-week training on the ground, often 3 times a week for 50 minutes of prescribed method exercises.
Pilates 12-week training on the ground, often 3 times a week for 50 minutes of prescribed method exercises.
Eligibility Criteria
You may qualify if:
- Women between the ages of 40 and 70;
- Be post menopausal (amenorrhea for at least 12 months);
- Medical release to perform physical activities.
- Do not present physical problems or cardiovascular complications that prevent the performance of physical exercises;
You may not qualify if:
- To present a history of stroke or acute myocardial infarction;
- Smoking;
- Diagnosis of Diabetes Mellitus.
- Present renal pathologies.
- Use medications that interfere with lipid metabolism;
- Use of antihypertensive drugs (except for the hypertensive group);
- Use hormone replacement therapies;
- Present gastrointestinal conditions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jaqueline Pontes Batista
Uberlândia, Minas Gerais, 38400-678, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Guilherme M Puga, Phd
Federal University of Uberlandia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 24, 2017
First Posted
August 13, 2018
Study Start
August 5, 2017
Primary Completion
December 20, 2017
Study Completion
March 28, 2018
Last Updated
March 22, 2022
Record last verified: 2022-03